Title : Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.

Pub. Date : 1989 Mar

PMID : 2648723






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin treatment significantly reduced mean day-time plasma glucose levels (10.2 +/- 1.2 vs 11.4 +/- 1.2 mmol/l, P less than 0.01) without enhancing mean day-time plasma insulin (43 +/- 4 vs 50 +/- 7 mU/l, NS) or C-peptide levels (1.26 +/- 0.12 vs 1.38 +/- 0.18 nmol/l, NS). Metformin insulin Homo sapiens
2 The clamp study revealed that metformin treatment was associated with an enhanced insulin-mediated glucose utilization (370 +/- 38 vs 313 +/- 33 mg.m-2.min-1, P less than 0.01), whereas insulin-mediated suppression of hepatic glucose production was unchanged. Metformin insulin Homo sapiens